Biznesradar bez reklam? Sprawdź BR Plus
Branża Biotechnologia
Stopy zwrotu
| Profil | 1t | 1m | 3m | 6m | YTD | 12m | 24m | 36m | 60m | 120m |
|---|---|---|---|---|---|---|---|---|---|---|
| MQR (MULTIQURE) | +0,29% | -7,16% | -52,94% | -41,91% | -60,70% | -73,05% | -83,27% | -70,90% | -96,11% | bd. |
| SLV (SELVITA) | +10,02% | -13,04% | -37,28% | -43,40% | -58,33% | -56,73% | -67,33% | -69,70% | -77,78% | bd. |
| GMT (GENOMTEC) | +6,33% | -10,17% | -33,21% | -59,04% | -31,45% | -47,90% | -65,72% | -75,65% | -75,28% | bd. |
| RVU (RYVU) | +9,49% | +4,65% | +5,39% | -22,91% | -33,58% | -27,86% | -62,96% | -66,97% | -71,06% | +4,29% |
| PTG (POLTREG) | +1,56% | -4,88% | -27,51% | +12,39% | -20,41% | -23,83% | -60,69% | -64,55% | bd. | bd. |
| URT (URTESTE) | +4,88% | +0,47% | -1,83% | +1,42% | +10,26% | -2,71% | -51,47% | -52,22% | -57,00% | bd. |
| MOC (MOLECURE) | -0,72% | -15,47% | -8,91% | +4,55% | -16,36% | -8,00% | -42,50% | -69,09% | -85,92% | bd. |
| BMX (BIOMAXIMA) | -1,50% | -14,50% | -16,67% | -22,27% | -29,05% | -34,23% | -40,62% | -47,87% | -67,55% | +85,01% |
| GRZ (GREENZEB) | -4,42% | -8,47% | -12,18% | +15,33% | -11,73% | -13,07% | -37,77% | bd. | bd. | bd. |
| SNG (SYNERGA) | +1,58% | -8,33% | -13,68% | +13,24% | -30,00% | -45,16% | -36,26% | -58,06% | -80,18% | +92,50% |
| ONO (ONESANO) | -6,32% | -19,09% | +26,69% | +6,27% | -9,64% | -20,89% | -35,86% | -43,72% | -61,93% | -11,51% |
| GX1 (GENXONE) | +2,22% | -13,21% | -18,44% | -23,33% | +15,29% | -5,35% | -34,29% | -28,13% | -81,64% | bd. |
| NNG (NANOGROUP) | -3,11% | -7,63% | -9,17% | -9,17% | -17,74% | -14,34% | -26,60% | +121,10% | -56,40% | bd. |
| SCP (SCPFL) | 0,00% | +8,17% | +4,69% | +26,33% | +4,99% | -5,42% | -12,91% | -13,33% | +22,95% | bd. |
| BCX (BIOCELTIX) | +1,59% | +0,72% | -13,03% | -16,25% | -9,66% | -27,06% | -10,13% | +11,27% | +105,27% | bd. |
| CTX (CAPTORTX) | +0,56% | -9,50% | -24,58% | -30,38% | -24,58% | +14,08% | -7,97% | -43,79% | -71,40% | bd. |
| MDB (MEDICOBIO) | +1,08% | -2,09% | -3,61% | -10,95% | -6,27% | -26,67% | -3,61% | -68,57% | -81,30% | -37,67% |
| RDG (READGENE) | -1,64% | -4,00% | -5,14% | -5,51% | -12,09% | -20,27% | -2,04% | +39,53% | +90,48% | +196,30% |
| GEN (GENOMED) | -10,81% | -19,12% | +10,00% | +36,51% | +43,28% | +15,58% | +27,48% | +1,98% | -10,17% | +94,21% |
| SCS (STEMCELLS) | +4,08% | +10,87% | +15,91% | +27,50% | +25,62% | +28,79% | +97,67% | +24,39% | -23,31% | -68,13% |
| SNT (SYNEKTIK) | +2,75% | -3,11% | -6,96% | +19,52% | +33,97% | +43,19% | +124,19% | +502,79% | +1 298,56% | +2 633,51% |
| S2B (SYN2BIO) | -0,47% | +1,11% | -4,19% | +121,84% | bd. | bd. | bd. | bd. | bd. | bd. |
Biznesradar bez reklam? Sprawdź BR Plus